Zrzavy, Tobias
Wielandner, Alice
Haider, Lukas
Bartsch, Sophie
Leutmezer, Fritz
Berger, Thomas
Nenning, Karl Heinz
Rauscher, Alexander
Rommer, Paulus http://orcid.org/0000-0001-5209-6647
Kasprian, Gregor
Funding for this research was provided by:
Medical University of Vienna
Article History
Received: 18 August 2021
Revised: 29 September 2021
Accepted: 29 September 2021
First Online: 8 October 2021
Change Date: 26 October 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00415-021-10855-5
Declarations
:
: Zrzavy Tobias has no conflict of interest relevant to this study. Wielandner Alice has no conflict of interest relevant to this study. Haider Lukas has no conflict of interest relevant to this study. Bartsch Sophie has no conflict of interest relevant to this study. Leutmezer Fritz has no conflict of interest relevant to this study. Berger Thomas has nothing to disclose for this study. Nenning Karl-Heinz has no conflict of interest relevant to this study. Rauscher Alexander has no conflict of interest to declare. Rommer Paulus has received honoraries for lectures/consultancy from AbbVie, Alexion, Almirall, Biogen, Merck, Novartis, Sandoz, Teva, has received research grants from Biogen, Merck, Roche. None resulted in a conflict of interest with regard to the submitted manuscript. Kasprian Gregor has no conflict of interest relevant to this study.
: The study was approved by the ethics committee of the Medical University of Vienna and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.